BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 15272051)

  • 1. Molecular recognition of corticotropin-releasing factor by its G-protein-coupled receptor CRFR1.
    Pioszak AA; Parker NR; Suino-Powell K; Xu HE
    J Biol Chem; 2008 Nov; 283(47):32900-12. PubMed ID: 18801728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling in human corticotroph tumours reveals distinct, neuroendocrine profiles.
    Cassarino MF; Ambrogio AG; Cassarino A; Terreni MR; Gentilini D; Sesta A; Cavagnini F; Losa M; Pecori Giraldi F
    J Neuroendocrinol; 2018 Sep; 30(9):e12628. PubMed ID: 29920815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different cAMP sources are critically involved in G protein-coupled receptor CRHR1 signaling.
    Inda C; Dos Santos Claro PA; Bonfiglio JJ; Senin SA; Maccarrone G; Turck CW; Silberstein S
    J Cell Biol; 2016 Jul; 214(2):181-95. PubMed ID: 27402953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis.
    Atwood BK; Lopez J; Wager-Miller J; Mackie K; Straiker A
    BMC Genomics; 2011 Jan; 12():14. PubMed ID: 21214938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deducing corticotropin-releasing hormone receptor type 1 signaling networks from gene expression data by usage of genetic algorithms and graphical Gaussian models.
    Trümbach D; Graf C; Pütz B; Kühne C; Panhuysen M; Weber P; Holsboer F; Wurst W; Welzl G; Deussing JM
    BMC Syst Biol; 2010 Nov; 4():159. PubMed ID: 21092110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VIP, CRF, and PACAP act at distinct receptors to elicit different cAMP/PKA dynamics in the neocortex.
    Hu E; Demmou L; Cauli B; Gallopin T; Geoffroy H; Harris-Warrick RM; Paupardin-Tritsch D; Lambolez B; Vincent P; Hepp R
    Cereb Cortex; 2011 Mar; 21(3):708-18. PubMed ID: 20699230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSE-MECC two-dimensional capillary electrophoresis analysis of proteins in the mouse tumor cell (AtT-20) homogenate.
    Chen X; Fazal MA; Dovichi NJ
    Talanta; 2007 Mar; 71(5):1981-1985. PubMed ID: 17637850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.
    Hauger RL; Risbrough V; Brauns O; Dautzenberg FM
    CNS Neurol Disord Drug Targets; 2006 Aug; 5(4):453-79. PubMed ID: 16918397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of molecules potentially involved in mediating the in vivo actions of the corticotropin-releasing hormone receptor 1 antagonist, NBI30775 (R121919).
    Post A; Ohl F; Almeida OF; Binder EB; Rücker M; Welt S; Binder E; Holsboer F; Sillaber I
    Psychopharmacology (Berl); 2005 Jun; 180(1):150-8. PubMed ID: 15682302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary adenylate cyclase-activating polypeptide stimulates corticotropin-releasing factor, vasopressin and interleukin-6 gene transcription in hypothalamic 4B cells.
    Kageyama K; Hanada K; Iwasaki Y; Sakihara S; Nigawara T; Kasckow J; Suda T
    J Endocrinol; 2007 Nov; 195(2):199-211. PubMed ID: 17951532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of vertebrate corticotropin-releasing factor genes.
    Yao M; Denver RJ
    Gen Comp Endocrinol; 2007; 153(1-3):200-16. PubMed ID: 17382944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role and action in the pituitary corticotroph of corticotropin-releasing factor (CRF) in the hypothalamus.
    Kageyama K; Suda T
    Peptides; 2009 Apr; 30(4):810-6. PubMed ID: 19124055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional response to corticotropin-releasing factor in AtT-20 cells.
    Peeters PJ; Göhlmann HW; Van den Wyngaert I; Swagemakers SM; Bijnens L; Kass SU; Steckler T
    Mol Pharmacol; 2004 Nov; 66(5):1083-92. PubMed ID: 15272051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mice that lack corticotropin-releasing factor (CRF) receptors type 1 show a blunted ACTH response to acute alcohol despite up-regulated constitutive hypothalamic CRF gene expression.
    Lee S; Smith GW; Vale W; Lee KF; Rivier C
    Alcohol Clin Exp Res; 2001 Mar; 25(3):427-33. PubMed ID: 11290855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Region specific gene expression profile in mouse brain after chronic corticotropin releasing factor receptor 1 activation: the novel role for diazepam binding inhibitor in contextual fear conditioning.
    Sherrin T; Blank T; Saravana R; Rayner M; Spiess J; Todorovic C
    Neuroscience; 2009 Aug; 162(1):14-22. PubMed ID: 19362130
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.